December 2014 FDA Recall Benzonatate by Zydus Pharmaceuticals Usa Inc
D-0325-2015 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on December 23, 2014 for the product Benzonatate. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0325-2015

Reason for Recall
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Initiated
12-23-2014
Reported
12-31-2014
Quantity
19,536 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals USA Inc
Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05

Batch or Lot Expiration Information

Lot# : MP2625, MP2626, MP2627 Exp 2/16; MP4875, MP4876, MP4877, MP4878 Exp 4/16; MP6482, MP6483, MP6484, MP6493, MP6494 Exp 6/16